ABSTRACT
PURPOSE: Large scalp defects pose a reconstructive problem especially in elderly patients. The purpose of the study is to describe our experience of oncologic scalp reconstruction using a dermal matrix (Integra). MATERIAL AND METHODS: We conducted a retrospective cohort study (January 2007 to March 2021) of patients who had undergone scalp tumor excision and reconstruction using Integra and a split-thickness skin graft (STSG). The primary end point was Integra and STSG success (defined by ≥75% percent take) and the secondary end point was postoperative complications. Both end points were assessed by the surgeon during follow-up. Demographic data, tumor characteristics, average defect size, time between stages and full-thickness scalp defects were characterized using descriptive statistics. Univariate and multivariate logistic regression models were used to evaluate the association between variables and end points. RESULTS: The sample included 70 patients with a mean (SD) age of 83.3 (7.0) years, 75.7% men and 92.9% with comorbidities. Mean (SD) defect area was 23 (17.0) cm2 and the mean (SD) first-to-second phase interval was 30.6 (8.4) days. Sixty-four patients (91.4%) underwent outpatient surgery. Integra and STSG success rates were 87.1% (95% CI: 77.69 to 93.74%) and 100%, respectively. The complications rate was 18.6% (95% CI: 9 to 28%). Mean (SD) follow-up was 18 (16.7) months. Univariate and multivariate logistic regression analysis showed no association between variables and the primary and secondary end points. CONCLUSIONS: Reconstruction of oncologic scalp defects using Integra can be performed under sedation and local anesthesia. Integra should be considered as firstline treatment for the reconstruction of scalp defects in elderly patients with comorbidities, given the low postoperative major complications rate and Integra and STSG take success.
Subject(s)
Plastic Surgery Procedures , Scalp , Aged , Aged, 80 and over , Chondroitin Sulfates , Collagen , Female , Humans , Male , Retrospective Studies , Scalp/surgery , Skin TransplantationSubject(s)
Pyoderma Gangrenosum/pathology , Skin Neoplasms/pathology , Skin Ulcer/drug therapy , Skin Ulcer/pathology , Anti-Bacterial Agents/therapeutic use , Biopsy, Needle , Buttocks/pathology , Diagnosis, Differential , Drug Therapy, Combination , Follow-Up Studies , Humans , Immunohistochemistry , Infant , Leg/pathology , Male , Pyoderma Gangrenosum/diagnosis , Pyoderma Gangrenosum/drug therapy , Rare Diseases , Recurrence , Severity of Illness Index , Skin Neoplasms/diagnosis , Skin Ulcer/diagnosis , Steroids/therapeutic use , Treatment OutcomeABSTRACT
INTRODUCTION: In numerous clinical practice guidelines, emphasis is placed on the need for coordinated care of psoriatic arthritis (PsA) between rheumatologists and the objective was to develop experience-based points to consider facilitating the implementation of multidisciplinary units (Dermatology/Rheumatology) for the management of patients with PsA. METHODS: A scientific committee of rheumatology and dermatology experts in the management of PsA, and with experience in joint care, discussed the critical aspects of multidisciplinary PsA Units. The discussion became the basis for a Delphi survey in two rounds submitted to a panel of 24 specialists in rheumatology and dermatology not involved in PsA units. The statements and practices that reached a consensus were summarized and further elaborated. RESULTS: After two Delphi rounds, agreement was reached for 49 of the 50 proposed statements. These included a justification of the units, objectives, and utilities, as well as operational aspects of the units, such as the minimal and ideal premises, referral criteria, and necessary resources. The statements were compiled in 11 points to consider. CONCLUSIONS: This consensus offers some points to consider, including premises and recommendations, for the development of specialized Units in the management of PsA based on expert opinion. We trust these guidelines may facilitate their implementation in the future. FUNDING: Pfizer.
Subject(s)
Arthritis, Psoriatic/diagnosis , Arthritis, Psoriatic/therapy , Dermatology/methods , Interprofessional Relations , Patient Care Team/standards , Practice Guidelines as Topic , Rheumatology/methods , Adult , Aged , Aged, 80 and over , Delphi Technique , Female , Humans , Male , Middle Aged , Patient Care Team/organization & administration , Surveys and QuestionnairesABSTRACT
Folliculitis is an inflammatory reaction in the superficial aspect of the hair follicle and can involve the follicular opening or the perifollicular hair follicles. The pilosebaceous unit of the follicle is divided into three compartments: the infundibulum (superficial part, outlined by the sebaceous duct), the isthmus (between the sebaceous duct and arrector pili protuberance), and the inferior segment (stem and hair bulb). This anatomical scheme forms the basis for any evaluation of the clinical manifestations of folliculitis. Most of the follicular conditions can be classified according to their anatomical location and histopathologic patterns. Clinically, the inflammation manifests as 1mm-wide vesicles, pustules, or papulopustules in acute cases; however, hyperkeratosis and keratotic plug formations are indicative of a chronic process. The presence of superficial pustules does not always imply an infectious origin, as there are many noninfectious types of folliculitis. In this review, we describe the different types of folliculitis based on their etiology, clinical manifestation, and treatment. We also discuss some newly described disorders and the latest information on their treatment.
Subject(s)
Folliculitis/diagnosis , Folliculitis/therapy , Hair Follicle/microbiology , Acute Disease , Adult , Child , Chronic Disease , Dermatomycoses/diagnosis , Dermatomycoses/therapy , Diagnosis, Differential , Female , Folliculitis/etiology , Folliculitis/pathology , Humans , Male , Risk Factors , Staphylococcal Skin Infections/diagnosis , Staphylococcal Skin Infections/therapyABSTRACT
Puesta al día de la inmunología de la lepra, analisando das respuestas inmunitarias a nivel humoral y celular, según diferentes invastigadores, en las diferentes formas clínicas y en los dos tipos de leprorreacción. La inmunidad inmediata no está alterada pero presenta defectos en su control y en la respuesta celular hay inmunodeficiencias, a veces totales, como falta de formación de granulomas hacia el M. leprae, parásito eminentemente intracelular y bien tolerado. Nosa ha demostrado ningún tipo de antígeno de histocompatibilidad que predisponga a la enfermedad. Se estudian los diferentes antígenos glicolópidos-fenólicos y los epítopes preteicos bacterianos. Continúa aún el reto de explicar el mecanismo enterno del inmunodéficit, confiando que la Ingeniería Genética pueda aclarado.